Nicotine Clinical Trial
Official title:
The Effect of Nicotine Delivery Rate on Reinforcement
Verified date | October 2018 |
Source | Yale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The dose-effect curve to estimate a threshold delivery rate for reinforcement. The project addresses the FDA Center for Tobacco Products (CTP) interest #1: Nicotine dependence threshold among youth and adults and impact of nicotine reduction on tobacco product use behavior (e.g., topography, compensation, switching, multiple use, initiation, cessation and relapse). IV nicotine, in contrast to ECs, can deliver precise, reproducible dosing, which is necessary for accurately assessing dose-response and threshold effects. The estimated threshold for reinforcement will establish a benchmark for evaluating the addictive potential of ECs and other inhaled nicotine products.
Status | Completed |
Enrollment | 18 |
Est. completion date | January 29, 2018 |
Est. primary completion date | January 29, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria: 1. Female and male smokers that smoke = 5 cigarettes per day for the past year 2. aged 18 to 30 years 3. urine cotinine levels > 100 ng/mL consistent with nicotine intake of an active smoker (23) 4. not seeking treatment at the time of the study for nicotine dependence 5. in good health as verified by medical history, screening examination, and screening laboratory tests 6. for women, not pregnant as determined by pregnancy screening, nor breast feeding, and using acceptable birth control methods. Exclusion Criteria: 1. history of major medical or psychiatric disorders that the physician investigator deems as contraindicated for the subject to be in the study 2. regular use of psychotropic medication (antidepressants, antipsychotics, or anxiolytics) 3. current alcohol or substance dependence for any other recreational or prescription drugs other than nicotine 4. urine drug screening indicating recent illicit drugs use (with the exception of marijuana). |
Country | Name | City | State |
---|---|---|---|
United States | VA Hospital | West Haven | Connecticut |
Lead Sponsor | Collaborator |
---|---|
Yale University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Peak Change on items of the Drug Effects Questionnaire (DEQ) | The peak change in the intensity of subjective effects as measured by the DEQ | up to 60 minutes post infusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
Completed |
NCT04124432 -
Behavioral Pharmacology of Cannabis and Nicotine
|
Phase 1 | |
Enrolling by invitation |
NCT04038515 -
Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes
|
Phase 2 | |
Completed |
NCT01223404 -
Nicotinic Modulation of the Default Network
|
N/A | |
Recruiting |
NCT05864586 -
Developing E-liquid Product Standards (Sweet Spot Study)
|
N/A | |
Completed |
NCT01227343 -
Nicotine and Brain Imaging Research Study
|
||
Completed |
NCT05317195 -
Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers
|
N/A | |
Withdrawn |
NCT03010995 -
The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study
|
Phase 1 | |
Active, not recruiting |
NCT04189146 -
Inner Engineering Yoga Program on Short and Long Term Health Effects (ISHA-Impact): A Longitudinal Study
|
N/A | |
Completed |
NCT05487456 -
Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence
|
N/A | |
Completed |
NCT03102931 -
Switching to Low Oxidant Content Cigarettes in Adult Smokers
|
N/A | |
Recruiting |
NCT06346353 -
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
|
||
Completed |
NCT05383508 -
Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes
|
N/A |